These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5789770)

  • 21. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 22. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
    GOLDBERG LI
    JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995
    [No Abstract]   [Full Text] [Related]  

  • 26. RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA.
    OTSUKA S; KOBAYASHI Y
    Biochem Pharmacol; 1964 Jul; 13():995-1006. PubMed ID: 14201142
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of intraneuronal monoamine oxidase in the regulation of norepinephrine synthesis.
    Weiner N; Bjur R
    Adv Biochem Psychopharmacol; 1972; 5():409-19. PubMed ID: 4403371
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of monoamine oxidase inhibitors.
    Baker GB; Coutts RT
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):395-403. PubMed ID: 2664891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
    Aleyassine H; Lee SH
    Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664
    [No Abstract]   [Full Text] [Related]  

  • 30. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selective inhibition by pargyline and phenelzine of oxidation of biogenic amines in vivo].
    Romanova LA; Gorkin VZ
    Farmakol Toksikol; 1969; 32(6):667-9. PubMed ID: 5381595
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats.
    Stanton HC; Bowman Z; Cooper CM
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):256-63. PubMed ID: 4244547
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of monoamine oxidase inhibitors on the disposition of intracisternally administered metaraminol-3H.
    Breese GR; Chase TN; Kopin IJ
    Biochem Pharmacol; 1970 Feb; 19(2):525-32. PubMed ID: 4396250
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 38. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z; Kraus P
    Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic treatment with phenelzine and other irreversible monoamine oxidase inhibitors downregulates I2-imidazoline receptors in the brain and liver.
    Alemany R; Olmos G; García-Sevilla JA
    Ann N Y Acad Sci; 1995 Jul; 763():506-9. PubMed ID: 7677366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.